Long-term cost-effectiveness of thrombectomy for acute ischaemic stroke in real life: An analysis based on data from the Swedish Stroke Register (Riksstroke)

April 9, 2017

Thrombectomy has a small effect on hospital costs except for the direct intervention cost. However, thrombectomy is highly likely to lead to substantial cost savings in the social service sector.

My name is Carmen Lahiff-Jenkins and I’m the Managing Editor of the International Journal of Stroke and I spoke to Katarina Steen Carlsson, PhD in Economics, from the Department of Clinical Sciences, Malmö, Health Economics, Lund University, Sweden who with a team of researchers from Lund investigated the long-term cost-effectiveness of thrombectomy after thrombolysis versus thrombolysis alone using real-world outcome data on need for health care, home help and nursing home care.

This research has been published online in the International Journal of Stroke in the article Long-term cost-effectiveness of thrombectomy for acute ischaemic stroke in real life: An analysis based on data from the Swedish Stroke Register (Riksstroke)

The international Journal of Stroke is the flagship publication of the World Stroke Organisation, please consider becoming a member.

Download article from here

00:0000:00

Thrombectomy accessibility after transfer from a primary stroke center: analysis of a 3-year prospective registry

April 9, 2017

No comprehensive study exists on Mechanical Thrombectomy accessibility for patients admitted to a primary stroke center without on-site interventional neuroradiology services.

My name is Carmen Lahiff-Jenkins and I’m the Managing Editor of the International Journal of Stroke and I spoke to Dr Denis Sablot from the Centre Hospitalier de Perpignan, Neurologie, France and submitting author of Thrombectomy accessibility after transfer from a primary stroke center: analysis of a 3-year prospective registry, this article is available online at the International Journal of Stroke website, hosted by SAGE.  

This podcast recordng was developed and produced by the World Stroke Organization.

Download article here. 

00:0000:00

Apixaban for treatment of embolic stroke of undetermined source (ATTICUS randomized trial) - Rationale and study design Tobias Geisler

February 12, 2017

 

 Article link here

Optimal secondary prevention of embolic stroke of undetermined source (ESUS) is not established. The current standard in these patients is acetylsalicylic acid (ASA), despite high prevalence of yet undetected paroxysmal atrial fibrillation (AF).

ESUS is caused by embolic disease and associated with a high risk of recurrent ischemic strokes and clinically silent cerebral ischemic lesions. The ATTICUS randomized trial will investigate the impact of AF detected by ICM and the effects of early anticoagulation with apixaban compared to antiplatelet therapy with ASA on the incidence of NIL after ESUS.

I’m Carmen Lahiff-Jenkins Managing Editor of the International Journal of Stroke and I spoke to Tobias Geisler, lead author for the Apixaban for treatment of embolic stroke of undetermined source (ATTICUS randomized trial) - Rationale and study design published in the International Journal of Stroke. 

00:0000:00

Impact of stroke education on middle school students and their parents: a cluster randomized trial a chat with João Pedro Marto

February 12, 2017

Impact of stroke education on middle school students and their parents: a cluster randomized trial a chat with João Pedro Marto

School students are an attractive target for stroke education due to the potential impact on stroke prevention and recognition. Additionally, these students can drive behavioral changes in their families. This trial, the results published in the International Journal of Stroke, found that school-based interventions might improve stroke knowledge in middle school students and their parents. I’m Carmen Lahiff-Jenkins, Managing Editor of the International Journal of Stroke and I spoke to lead author João Pedro Marto.

00:0000:00

Global Stroke Statistics

November 27, 2016

The Global Stroke Statistics paper is up to date data on incidence, mortality, and case-fatality for stroke are important for setting the agenda for prevention and healthcare. Carmen Lahiff-Jenkins, Managing Editor of the International Journal of Stroke spoke to Tharshanah Thayabaranathan. 

http://wso.sagepub.com/content/early/2016/10/27/1747493016676285.abstract

 

00:0000:00

Cheryl Carcel - Stroke Society Australasia

September 26, 2016
Paid work is an important marker to stroke recovery, I’m Carmen Lahiff-Jenkins and I spoke to Cheryl Carcel clinical research fellow and research coordinator at The George Institute for Global Health.
Cheryl Carcel's substudy, of the POISE study looked at unpaid and paid work after 12 months after stroke, she presented her data at the Stroke Society Australasia meeting in Brisbane. 
00:0000:00

CT-Angiography source images indicate less fatal outcome despite coma of patients in the Basilar Artery International Cooperation Study (BASICS)

September 21, 2016

CT-Angiography source images indicate less fatal outcome despite coma of patients in the Basilar Artery International Cooperation Study (BASICS) Carmen Lahiff-Jenkins, Managing Editor of the International Journal of Stroke spoke to author Lars-Peder Pellesen.   


00:0000:00

1 year on, AVERT trial results

August 30, 2016

IJS Managing Editor, Carmen Lahiff-Jenkins spoke to Professor Julie Bernhardt at this years Stroke Society Australasia/APSC meeting in Brisbane.  

00:0000:00

Adam Kirton: Diffusion imaging of cerebral diaschisis in childhood arterial ischemic stroke

July 27, 2016

Diffusion imaging of cerebral diaschisis in childhood arterial ischemic stroke, carmen Lahiff-Jenkins spoke to Adam Kirton submitting author. 

00:0000:00

Albert Yoo and David Leibeskind talk collateral imaging SSA/APSC

July 19, 2016
The role of collateral imaging for acute revasculization therapy, do we need it or should we just open the artery? Hi, I’m Carmen Lahiff-Jenkins, Managing Editor of the International Journal of Stroke and I spoke to Stroke Society Australasia /Asia Pacific Stroke Conference keynote speakers Albert Yoo and David Liebeskind who stood on opposite sides of the collateral imaging debate, you can hear a summary of this debate in this podcast.

00:0000:00